Ropivacaine Hydrochloride Injection

DRUG4 trials

Sponsors

Ilse van de Wijgert, Shanghai Hengrui Pharmaceutical Co., Ltd., The Third Xiangya Hospital of Central South University

Conditions

Fusion of SpineLumbar Disc DiseaseLumbar Disc HerniationLumbar RadiculitisLumbar Spinal StenosisLumbar Spine DiseaseLumbar SpondylolisthesisLumbar Spondylosis

Phase 2

Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management

Shanghai Hengrui Pharmaceutical Co., Ltd.Thoracoscopic Lobectomy

Start: 2023-02-21End: 2023-06-30Target: 96Updated: 2023-03-15

Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA

TerminatedNCT06509958

Shanghai Hengrui Pharmaceutical Co., Ltd.Postoperative Pain Management in Total Knee Arthroplasty

Start: 2024-08-20End: 2024-10-10Updated: 2024-10-30

Phase 3

A Clinical Trial Evaluating the Efficacy and Safety of Local Infiltration of RF16001 for Injection for Analgesia After Total Hip Arthroplasty in China

Enrolling by invitationNCT07872826

The Third Xiangya Hospital of Central South UniversityPain After Abdominal Surgery

Start: 2026-10-10End: 2027-10-31Target: 300Updated: 2026-10-14

Phase 4

Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery

CompletedNCT05345249

Ilse van de WijgertFusion of Spine, Lumbar Disc Disease, Lumbar Disc Herniation +8

Start: 2022-06-01End: 2024-01-19Updated: 2024-04-17